Health Tidings Mergers & AcquisitionsLEO Pharma Agrees to Acquire Dersimelagon, Expanding Late-Stage Rare Dermat... LEO Pharma Agrees to Acquire Dersimelagon, Expanding Late-Stage Rare Dermat... Read Post »
Health TidingsBlossomHill’s BH-30643 Gets FDA Fast Track Designation for EGFR C797S-Pos... BlossomHill’s BH-30643 Gets FDA Fast Track Designation for EGFR C797S-Pos... Read Post »
Clinical TrialsAvexitide Reduces Level 2 and Level 3 Hypoglycemic Events by 55% in Phase 3... Avexitide Reduces Level 2 and Level 3 Hypoglycemic Events by 55% in Phase 3... Read Post »
ResearchCan Dexamethasone Become a Noninvasive Option for Retinopathy of Prematurit... Can Dexamethasone Become a Noninvasive Option for Retinopathy of Prematurit... Read Post »
Health TidingsEli Lilly Joins $30 Million Series A to Advance Leal’s Schizophrenia and ... Eli Lilly Joins $30 Million Series A to Advance Leal’s Schizophrenia and ... Read Post »
Clinical TrialsInnoCare Receives China Approval for Phase III Head-to-Head Mesutoclax Tria... InnoCare Receives China Approval for Phase III Head-to-Head Mesutoclax Tria... Read Post »
Clinical TrialsKRYSTAL-10: Adagrasib Plus Cetuximab Does Not Significantly Improve PFS or ... KRYSTAL-10: Adagrasib Plus Cetuximab Does Not Significantly Improve PFS or ... Read Post »
GenericsBiocon Receives U.S. FDA Approval for YESINTEK® Single-Dose Prefilled Auto... Biocon Receives U.S. FDA Approval for YESINTEK® Single-Dose Prefilled Auto... Read Post »
Health TidingsFDA Grants Fast Track Designation to PIKTOR Plus Paclitaxel for Biomarker-S... FDA Grants Fast Track Designation to PIKTOR Plus Paclitaxel for Biomarker-S... Read Post »
Health TidingsFate Therapeutics Advances Fixed-Dose FT819 Into Phase 2 Lupus Nephritis Tr... Fate Therapeutics Advances Fixed-Dose FT819 Into Phase 2 Lupus Nephritis Tr... Read Post »
Mergers & AcquisitionsOmniAb and Lilly Launch New Ion Channel Discovery Collaboration Worth Up to... OmniAb and Lilly Launch New Ion Channel Discovery Collaboration Worth Up to... Read Post »
Health TidingsEyePoint Reports Mixed Phase 3 Results for DURAVYU in Wet AMD EyePoint Reports Mixed Phase 3 Results for DURAVYU in Wet AMD Read Post »
Health TidingsGalmed Reports 3–4-Fold Increase in Prostate Cancer Cell Death with Aramc... Galmed Reports 3–4-Fold Increase in Prostate Cancer Cell Death with Aramc... Read Post »
Health TidingsSpevatamig Receives FDA Fast Track Designation for Advanced and Metastatic ... Spevatamig Receives FDA Fast Track Designation for Advanced and Metastatic ... Read Post »
Health TidingsEnhertu Improves Progression-Free Survival in First-Line HER2-Mutant NSCLC ... Enhertu Improves Progression-Free Survival in First-Line HER2-Mutant NSCLC ... Read Post »
Health TidingsMHRA Approves Vimseltinib for Adults with Tenosynovial Giant Cell Tumour MHRA Approves Vimseltinib for Adults with Tenosynovial Giant Cell Tumour Read Post »
Clinical Trialsargenx Reports Positive Phase 3 ALKIVIA Results for Efgartigimod in Autoimm... argenx Reports Positive Phase 3 ALKIVIA Results for Efgartigimod in Autoimm... Read Post »
Health TidingsAbelZeta Secures IND Clearance for C-CAR039 in Relapsed or Refractory Large... AbelZeta Secures IND Clearance for C-CAR039 in Relapsed or Refractory Large... Read Post »
Clinical TrialsAstraZeneca Discontinues Phase III eVOLVE-Lung02 Trial of Volrustomig in Me... AstraZeneca Discontinues Phase III eVOLVE-Lung02 Trial of Volrustomig in Me... Read Post »
Health TidingsPfizer and Valneva Advances Lyme Disease Vaccine to EMA Review After Positi... Pfizer and Valneva Advances Lyme Disease Vaccine to EMA Review After Positi... Read Post »
Clinical TrialsAstraZeneca and HUTCHMED Report Positive SAFFRON Phase III Results in MET-D... AstraZeneca and HUTCHMED Report Positive SAFFRON Phase III Results in MET-D... Read Post »
ResearchLong-Acting Broadly Neutralising Antibodies Delay HIV Viral Rebound After A... Long-Acting Broadly Neutralising Antibodies Delay HIV Viral Rebound After A... Read Post »
New Drug ApprovalFDA Approves TAUKLARIFY, Expanding Tau PET Imaging for Alzheimer’s Diseas... FDA Approves TAUKLARIFY, Expanding Tau PET Imaging for Alzheimer’s Diseas... Read Post »
Clinical TrialsSecukinumab Nearly Doubles Sustained Remission in Relapsed Polymyalgia Rheu... Secukinumab Nearly Doubles Sustained Remission in Relapsed Polymyalgia Rheu... Read Post »
Clinical TrialsArkBio’s Ziresovir Advances Into FDA-Cleared Phase II Trial in Critically... ArkBio’s Ziresovir Advances Into FDA-Cleared Phase II Trial in Critically... Read Post »
Medical DevicesFDA Clears Galaxy Buds for Adults With Mild to Moderate Hearing Loss FDA Clears Galaxy Buds for Adults With Mild to Moderate Hearing Loss Read Post »
Health TidingsCaribou Reports Mature CAR-T Trials Results for Vispa-cel in LBCL and CB-01... Caribou Reports Mature CAR-T Trials Results for Vispa-cel in LBCL and CB-01... Read Post »
New Drug ApprovalBMS’s ZENBEXUS Becomes First FDA-Approved CELMoD for RRMM BMS’s ZENBEXUS Becomes First FDA-Approved CELMoD for RRMM Read Post »
Mergers & AcquisitionsZealand Pharma Sells Rusfertide Royalty Rights to Royalty Pharma for $100 M... Zealand Pharma Sells Rusfertide Royalty Rights to Royalty Pharma for $100 M... Read Post »
New Drug ApprovalChina Approves Ivonescimab Combination for First-Line Squamous NSCLC China Approves Ivonescimab Combination for First-Line Squamous NSCLC Read Post »
Health TidingsTHPharm Bets on Reverse Drug Development, Linking Drug Effects to New Disea... THPharm Bets on Reverse Drug Development, Linking Drug Effects to New Disea... Read Post »
Clinical TrialsClearmind Advances CMND-100 Trial into AUD After Positive Safety Review Clearmind Advances CMND-100 Trial into AUD After Positive Safety Review Read Post »
Health TidingsLilly Escalates Legal Action Against U.S. Sellers of Unapproved Retatrutide Lilly Escalates Legal Action Against U.S. Sellers of Unapproved Retatrutide Read Post »
Clinical TrialsINGREZZA Improves Quality of Life and Daily Functioning in Phase 4 Tardive ... INGREZZA Improves Quality of Life and Daily Functioning in Phase 4 Tardive ... Read Post »
Clinical TrialsLecanemab in the Real World: Duke Study Reveals How Alzheimer’s Therapy P... Lecanemab in the Real World: Duke Study Reveals How Alzheimer’s Therapy P... Read Post »
Health TidingsNatera and Kupando Collaborate on Phase 1 Trial of KUP-101 Using Latitude t... Natera and Kupando Collaborate on Phase 1 Trial of KUP-101 Using Latitude t... Read Post »
Health TidingsSagimet Receives FDA Clearance to Advance Phase 3 Denifanstat Acne Trial Sagimet Receives FDA Clearance to Advance Phase 3 Denifanstat Acne Trial Read Post »
Health TidingsRemepy Advances Hybridopa Toward Phase III After Positive Parkinson’s Dis... Remepy Advances Hybridopa Toward Phase III After Positive Parkinson’s Dis... Read Post »
Clinical TrialsNeOnc Reports 48.9% Six-Month PFS With NEO100 in IDH1-Mutant Glioma NeOnc Reports 48.9% Six-Month PFS With NEO100 in IDH1-Mutant Glioma Read Post »
Health TidingsAttralus’ Zamubafusp Alfa Gets FDA Fast Track for AL Amyloidosis Attralus’ Zamubafusp Alfa Gets FDA Fast Track for AL Amyloidosis Read Post »
Health TidingsCan-Fite Advances Namodenoson in Liver Cancer and Piclidenoson in Psoriasis Can-Fite Advances Namodenoson in Liver Cancer and Piclidenoson in Psoriasis Read Post »
Clinical TrialsREZILIENT3 Trial Shows PFS Benefit With Zipalertinib Plus Chemotherapy in N... REZILIENT3 Trial Shows PFS Benefit With Zipalertinib Plus Chemotherapy in N... Read Post »
Clinical TrialsLeap’s Sirexatamab Misses PFS Endpoint in mCRC but Shows Greater Benefit ... Leap’s Sirexatamab Misses PFS Endpoint in mCRC but Shows Greater Benefit ... Read Post »
Health TidingsDefinium’s DT120 Meets All Key Endpoints in Phase 3 Voyage Trial for Gene... Definium’s DT120 Meets All Key Endpoints in Phase 3 Voyage Trial for Gene... Read Post »
Health TidingsAnnexon Adds Month 24 Endpoint to Phase 3 ARCHER II Trial of Vonaprument in... Annexon Adds Month 24 Endpoint to Phase 3 ARCHER II Trial of Vonaprument in... Read Post »
Health TidingsBelite Bio’s Tinlarebant Wins FDA Priority Review for Stargardt Disease Belite Bio’s Tinlarebant Wins FDA Priority Review for Stargardt Disease Read Post »
New Drug ApprovalUK Becomes First European Country to Authorise Orforglipron UK Becomes First European Country to Authorise Orforglipron Read Post »
New Drug ApprovalEnhertu® Plus Pertuzumab Approved in China as First-Line Treatment for HER... Enhertu® Plus Pertuzumab Approved in China as First-Line Treatment for HER... Read Post »
Health TidingsPDS Biotech Shifts Focus to PDS0301, Discontinues PDS0101 Phase 3 Program PDS Biotech Shifts Focus to PDS0301, Discontinues PDS0101 Phase 3 Program Read Post »
Clinical TrialsBEL512 Shows Positive Phase 2 Results in CRSwNP, Supporting Potential for S... BEL512 Shows Positive Phase 2 Results in CRSwNP, Supporting Potential for S... Read Post »
